Study Stopped
We have decided to withdraw this research study due to the receipt of funding for a similar study that aligns more closely with our current research priorities and available resources.
QOL and GI Outcomes in Malignancies
Psychosocial Determinants of Health-Related Quality of Life (QOL) and Gastrointestinal (GI) Functional Outcomes During Treatment for Malignancies
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2021
CompletedFirst Posted
Study publicly available on registry
March 25, 2021
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2024
CompletedNovember 26, 2024
November 1, 2024
7 days
March 22, 2021
November 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Health Related Quality of Life as Measured by Perceived Stress Scale
Perceived Stress Scale (Scale of 1-40 with higher scores indicating higher stress)
Up to 10 weeks.
Health Related Quality of Life as Measured by University of California, Los Angeles (UCLA) Loneliness Scale
UCLA Loneliness Scale (Scale of 20-80 with higher scores indicating higher loneliness)
Up to 10 weeks.
Health Related Quality of Life as Measured by Interpersonal Support Evaluation List
Interpersonal Support Evaluation List (12 item questionnaire evaluated on a 4-point Likert scale with a higher score indicating higher support).
Up to 10 weeks.
Health Related Quality of Life as Measured by Functional Assessment of Cancer Therapy General - 7 Item Version (FACT-G7)
FACT-G7 (Scale of 0-28 with higher scores indicating better quality of life)
Up to 10 weeks.
Health Related Quality of Life as Measured by Functional Assessment of Cancer Therapy (FACT) Hepatobiliary-Pancreatic Symptom Index (FHSI)-18
FACT FHSI-18 (Scale of 0-72 with lower scores indicating better quality of life)
Up to 10 weeks.
The Gastrointestinal Symptom Rating Scale (GSRS)
GSRS (Scale of 0-78 with higher scores indicating worse gastrointestinal symptoms)
Up to 10 weeks.
Study Arms (2)
Psychosocial Symptom Management Intervention (PSMI) Experimental Condition Arm
EXPERIMENTALParticipants in this group will receive the Cognitive Behavioral Therapy (CBT)-based skills over a 10-week period.
Usual Clinical Care Control Arm
ACTIVE COMPARATORParticipants in this group will receive standard education.
Interventions
The CBT skills target reducing anxiety, (e.g., relaxation), changing negative appraisals (e.g., cognitive restructuring), coping skills training (e.g., enhancing adaptive skills), behavioral activation, interpersonal skills (e.g., communication skills) and building or enhancing social networks. The intervention will be administered online, and each module will last about 1-hour.
Patients randomized to standard clinical care will receive standard education based on various resources (e.g., National Cancer Institute) relevant to pancreatic cancer.
Eligibility Criteria
You may qualify if:
- Greater than 18 years of age
- Spanish or English speaker with ability to read one of these languages
- Diagnosis of pancreatic cancer .
- Willingness to be assessed at diagnosis, during neoadjuvant chemotherapy (if applicable), preoperatively (if applicable - unless time of diagnosis is preoperative visit), and postoperatively for up to two years following surgery.
You may not qualify if:
- Patients unable to read Spanish or English, as they will be unable to complete surveys.
- History of previous invasive cancer or treatment with chemotherapy, as they may have a different baseline functional status, quality of life, and gastrointestinal function compared to the normal healthy population, per principal investigator discretion, based on a case-by-case review.
- Prior inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis) within the past six months as these conditions can interfere with adequate participation in assessments, per principal investigator discretion, based on a case-by-case review.
- Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank Penedo, PhD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 22, 2021
First Posted
March 25, 2021
Study Start
October 1, 2024
Primary Completion
October 8, 2024
Study Completion
October 8, 2024
Last Updated
November 26, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share